globe
usa
magnifying-glass
checkbox
g-plus
rss
youtube
fb-round
connect-with-us-in
connect-with-us-twitter
youtube2
facebook
linkedin
twitter
☰
MEDINOL
About Us
NIR Legacy
Management
News
PRODUCTS
EluNIR
NC Gallant
Gallant
ChampioNIR
X-Suit NIR
TECHNOLOGIES
Flexx²
WiZeCell
eDES Coating
QualitySurface
CLINICAL
Clinical Program
WHERE TO BUY
DISTRIBUTORS ZONE
Sign In
CONTACT
Contact Us
Join Us
The website you have requested may contain information on products or uses of such products that are not approved in your country. For specific product and country information please contact Medinol
Continue
Products
EluNIR - NIREUS
Clinical
Clinical Program
EluNIR – NIREUS
At a Glance
EluNIR – NIREUS
0.04mm in-stent late-loss at 6 months
3.4% target lesion failure at 12 months
EluNIR was found non-inferior to Resolute Integrity in a broad, less selected ‘more comers’ population
In Stent Late-Loss at 6 Months (mm)
TLF/MACE at 12 Months
Watch Dr. David Kandzari as he reviews the EluNIR clinical program